Safety Warning
Always read the manufacturer's instructions regarding the medications you are currently taking before taking the test. • Fertility-promoting drugs containing the hormone hCG can lead to erroneous results (these fertility promoting drugs are usually given as an injection and a test too close to the last injection may produce an incorrect \"Pregnant\" result). • Other fertility treatments (such as clomiphene citrate), pain relievers and hormonal contraceptives (birth control pills, e.g. ex.) should not affect the result. • If you have recently stopped your hormonal contraception or are using fertility treatments like clomiphene citrate, your cycles may be irregular, which could lead you to test too early. • If you have been pregnant recently (even though you have not reached term), you may get an incorrect \"Pregnant\" result. • Ectopic pregnancy, ovarian cysts, menopause or very rare medical conditions can lead to erroneous results. • If you get a \"pregnant\" result, you may later receive a negative result due to a natural miscarriage that may occur in the early stages of pregnancy. If you get unexpected results, talk to your doctor. Clearblue Pratique et Rapide is a pregnancy test manufactured by SPD Swiss Precision Diagnostics GmBH and distributed by Procter & Gamble Pharmaceuticals France SAS. It is recommended to carry out the test as soon as the presumed date of menstruation. If in doubt about the result obtained, consult your doctor. This in vitro diagnostic medical device is a regulated health product which bears the CE mark under this regulation. Read the package leaflet carefully and seek advice from a healthcare professional. Internal referencing number: 21/03/PROCTER/GP/007. Completion date: 22/03/2021. SPD Swiss Precision Diagnostics GmbH, Route de St Georges 47, 1213 Petit-Lancy, Geneva, Switzerland. 0 805 540 267. www.clearblue.com. Name and address of authorized representative: MDSS GmbH, Schiffgraben 41 Hannover 30175, Germany: [email protected].
